CHI Announces Identification & Characterization of Cancer Stem Cells Short Course

Cambridge Healthtech Institute's Identification & Characterization of Cancer Stem Cells Short Course is being held at the Molecular Med TRI-CON 2013 on February 12th at The Moscone North Convention Center in San Francisco.
Dec. 19, 2012 - PRLog -- NEEDHAM, MASS. – Cambridge Healthtech Institute releases full details for its Identification & Characterization of Cancer Stem Cells Short Course taking place on February 12, 2013 at the Moscone North Convention Center in San Francisco, CA.  This course will provide an overview of the unique challenges of isolation and characterization of cancer stem cells, including identification and validation of surface markers, isolating CSCs from tumor cell populations and adult stem cells, and establishing, maintaining and working with cell lines.

Featured Speakers Include:

• Jaspal Khillan, Ph.D., Associate Professor, Microbiology and Molecular Genetics, University of Pittsburgh
• Marek Malecki, M.D., Ph.D., Associate Professor of Genetics, Genomics, and Gene Therapy, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences
• Jennie Mather, Senior Vice President, Stem Cell Technologies, Macrogenics, Inc.
• Kristen Smith, Ph.D., Scientist, Eclipse Pharmaceuticals

Advance registration discounts are available until January 11, 2013. To view the entire conference agenda and to register, please visit

To inquire about sponsoring and/or exhibiting, contact Jon Stroup at 781-972-5483 or, or Joseph Vacca at 781-972-5431 or

Writers and editors are encouraged to attend. To request a press pass, contact Lisa Scimemi at

About Cambridge Healthtech Institute (

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and Cambridge Healthtech Media Group.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

About Molecular Med Tri-Conference 2013 (

The 20th International Molecular Med Tri-Conference is the leading drug discovery research event covering a broad spectrum of cutting-edge topics within molecular medicine with scientific, business and regulatory viewpoints. Join over 3,000 of your colleagues in interactive lectures, discussions, and various networking receptions to hear differing views and perspectives on poignant issues facing you and our industry today. Spanning five days, the Tri-Conference includes 5 Concurrent Symposia, the Emerging Molecular Diagnostics Partnering Forum, 15 Afternoon & Dinner Short Courses and 15 Conference Programs.

Laura Norton
Cambridge Healthtech Institute
Email:*** Email Verified
Tags:Molecular Med Tri-Conference, Cancer, Stem Cells, Cambridge Healthtech Institute
Industry:Biotech, Technology
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Daily News
Weekly News

Daily News
Weekly News
PTC News

Dec 19, 2012 News

Like PRLog?
Click to Share